0.0200CAD0.00%Mkt Cap: 918361 CADP/E: —Last update: 2026-05-25
Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with a focus on nutraceuticals and pharmaceuticals in Canada. The company offers generic ophthalmic prescri…
Industry Peers
Drug Manufacturers - Specialty & Generic155.29BSEKP/E 172.0
58.11BTRYP/E 27.8
55.80BEURP/E 22.1
33.63BPLNP/E 21.9
24.50BUSDP/E 21.3
18.90BUSD—
15.76BUSDP/E 24.1
13.30BSEKP/E 40.0
Indicators:|
Key Statistics
Company
Market Cap918.36K CAD
Enterprise Value2.29M CAD
Revenue (TTM)—
Gross Profit0 CAD
Net Income (TTM)-335.06K CAD
Revenue/Share—
Last Price0.0200 CAD
Fiscal Year EndOct 2025
MR QuarterJan 2026
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-0.83
EPS (TTM)-0.01
EPS (Forward)—
52W Range
0.02000% of range0.0400
52W High0.0400 CAD
52W Low0.0200 CAD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE23.61%
ROA-657.16%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-124.07K CAD
CapEx (TTM)—
FCF Margin—
FCF Yield-18.12%
Net Debt1.07M CAD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-0.73
Current Ratio0.02
Quick Ratio0.01
Book Value/Sh-0.0240 CAD
Cash/Share0.0000 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.61.22M
Float33.55M
Insiders45.20%
Institutions0.00%
Short Interest
Short Ratio1.6d
Short % Out.0.00%
Shares Short760
Short (prev mo.)760
Technical
SMA 500.0200 (-0.0%)
SMA 2000.0267 (-25.2%)
Beta0.47
S&P 52W Chg28.31%
Avg Vol (30d)300
Avg Vol (10d)0
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—